Skip to main content
Fig. 5 | Alzheimer's Research & Therapy

Fig. 5

From: Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer’s disease: randomized, double-blind, placebo-controlled study

Fig. 5

Day 28 mean change in computerized cognitive test battery elect from baseline across treatment groups in Caucasian patients with early Alzheimer’s disease (AD) (ALZ1005 safety population). a Paired associated learning (PAL) 6 pattern errors adjusted. b Reaction time (RTI) median five-choice reaction time. c Spatial working memory (SWM) between errors 4–8 boxes

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193